Powerful cancer alliance joins cost-effectiveness drug crusade – FiercePharma
The American Society of Clinical Oncology unveiled its framework for assessing cancer drugs earlier this summer, breaking new ground in helping doctors size up competing treatments. Now, the National Comprehensive Cancer Network is going a few steps farther.As Reuters reports, the NCCN will offer a tool to compare various drugs by their costs, benefits and… Read More »